CompletedPhase 3NCT01962571
Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial
Studying Isolated optic neuritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Eye Hospital, Freiburg
- Principal Investigator
- Wolf A. Lagrèze, Prof.Eye Hospital, Medical Center - University of Freiburg
- Intervention
- Erythropoietin alfa(drug)
- Enrollment
- 108 target
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2014 – 2019
Study locations (11)
- Medical Center - University of Freiburg, Eye Hospital, Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Heidelberg University Hospital, Department of Neurooncology, Heidelberg, Baden-Wurttemberg, Germany
- Tuebingen University Hospital, Tübingen, Baden-Wurttemberg, Germany
- University Hospital Erlangen, Erlangen, Bavaria, Germany
- University Hospital of Munich, Munich, Bavaria, Germany
- University Hospital Klinikum rechts der Isar, Munich, Munich, Bavaria, Germany
- University Medical Center Göttingen, Göttingen, Lower Saxony, Germany
- Hannover Medical School, Hanover, Lower Saxony, Germany
- Duesseldorf University Hospital, Düsseldorf, North Rhine-Westphalia, Germany
- University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Rhineland-Palatinate, Germany
- University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Collaborators
German Federal Ministry of Education and Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01962571 on ClinicalTrials.govOther trials for Isolated optic neuritis
Additional recruiting or active studies for the same condition.